SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 11.378
EU - Europa 1.249
AS - Asia 1.173
SA - Sud America 178
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 16
OC - Oceania 5
Totale 14.126
Nazione #
US - Stati Uniti d'America 11.339
SG - Singapore 586
CN - Cina 271
IT - Italia 200
DE - Germania 156
UA - Ucraina 148
BR - Brasile 146
RU - Federazione Russa 123
FR - Francia 121
SE - Svezia 114
PL - Polonia 99
IE - Irlanda 90
VN - Vietnam 84
FI - Finlandia 82
HK - Hong Kong 70
GB - Regno Unito 55
BD - Bangladesh 36
KR - Corea 32
JP - Giappone 29
CA - Canada 19
IN - India 15
CZ - Repubblica Ceca 13
MX - Messico 13
AR - Argentina 11
BE - Belgio 11
ID - Indonesia 8
NL - Olanda 8
TR - Turchia 8
ES - Italia 7
ZA - Sudafrica 7
EC - Ecuador 6
AU - Australia 5
CH - Svizzera 5
IQ - Iraq 5
AT - Austria 4
CL - Cile 4
CO - Colombia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
VI - Stati Uniti Isole Vergini 1
Totale 14.004
Città #
Woodbridge 3.207
Wilmington 2.825
Houston 2.498
Fairfield 365
Singapore 346
Chandler 268
Ashburn 229
Ann Arbor 221
Seattle 138
San Jose 125
Jacksonville 117
Cambridge 116
Beijing 100
Kraków 85
Dublin 84
Rome 80
New York 77
Hong Kong 67
Council Bluffs 65
Medford 63
Dearborn 62
Santa Clara 60
Helsinki 53
Los Angeles 47
Zhengzhou 47
The Dalles 41
Milan 35
Ho Chi Minh City 29
Lawrence 29
Boardman 26
Tokyo 24
Hanoi 23
Lauterbourg 23
Munich 22
São Paulo 22
Menlo Park 20
San Diego 18
Phoenix 16
San Francisco 16
Buffalo 15
Moscow 15
Palo Alto 14
Chicago 13
Redondo Beach 13
Shanghai 13
Mülheim 12
Warsaw 12
Brussels 11
Montreal 11
Nanjing 11
Orem 11
Verona 11
Dallas 10
London 10
Stockholm 9
Creede 8
Falls Church 8
Jakarta 8
Brno 7
Columbus 7
Denver 7
Nuremberg 7
Amsterdam 6
Ankara 6
Belo Horizonte 6
Boston 6
Charlotte 6
Dong Ket 6
Hefei 6
North Bergen 6
Olomouc 6
Rio de Janeiro 6
Schiffdorf 6
Atlanta 5
Boydton 5
Brooklyn 5
Johannesburg 5
Kunming 5
Manchester 5
Poplar 5
Redwood City 5
University Park 5
Chennai 4
Colorado Springs 4
Dhaka 4
Frankfurt am Main 4
Guangzhou 4
Madrid 4
Nanchang 4
Southport 4
Anápolis 3
Auburn Hills 3
Brasília 3
Brescia 3
Chengdu 3
Curitiba 3
Guayaquil 3
Honolulu 3
Jinan 3
Lausanne 3
Totale 12.105
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 580
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 515
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 495
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 491
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 489
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 487
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 484
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 480
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 478
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 473
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 470
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 470
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 469
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 466
Multidrug resistance after lamivudine therapy for chronic hepatitis B 466
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 465
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 463
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 454
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 445
Aciclovir, herpes viruses and HIV: a never-ending story 436
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 431
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 426
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 402
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 400
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 398
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 395
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 395
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 386
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 383
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 369
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 307
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 107
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 105
Therapy and prevention of infective endocarditis 46
Totale 14.126
Categoria #
all - tutte 30.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022417 0 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/2025795 24 170 95 44 48 30 61 34 121 61 55 52
2025/20261.401 97 57 137 156 128 53 276 127 161 97 68 44
2026/2027154 76 78 0 0 0 0 0 0 0 0 0 0
Totale 14.126